Supporting Information for Designated Low-Priority Substances

Below are the supporting materials for the 20 low-priority substances designated in February 2020. Each document includes the information, analysis, and basis for the designation. These documents are also available in their respective dockets.

• Supporting Information for DPMA (pdf) (1.12 MB, February 20, 2020)
• Supporting Information for Dipropylene Glycol (pdf) (1.47 MB, February 20, 2020)
• Supporting Information for Dimethyl Malonate (pdf) (1.11 MB, February 20, 2020)
• Supporting Information for Tripropylene Glycol (pdf) (1.24 MB, February 20, 2020)
• Supporting Information for Tripropylene Glycol n-Butyl Ether (pdf) (1.11 MB, February 20, 2020)
• Supporting Information for Diethyl Malonate (pdf) (1.18 MB, February 20, 2020)
• Supporting Information for D-Gluconic Acid (pdf) (1.81 MB, February 20, 2020)
• Supporting Information for Potassium Gluconate (pdf) (1.77 MB, February 20, 2020)
• Supporting Information for Sodium Gluconate (pdf) (1.82 MB, February 20, 2020)
• Supporting Information for Glucono-delta-lactone (pdf) (1.85 MB, February 20, 2020)
• Supporting Information for Calcium Gluconate (pdf) (1.75 MB, February 20, 2020)
• Supporting Information for 1-Octadecanol (pdf) (5.72 MB, February 20, 2020)
• Supporting Information for 1,1'-Dimethyldiethylene Glycol (pdf) (4.37 MB, February 20, 2020)
• Supporting Information for Dibutyl Sebacate (pdf) (1.08 MB, February 20, 2020)
• Supporting Information for Sodium Glucoheptonate (pdf) (1.07 MB, February 20, 2020)
• Supporting Information for 1,2-Hexanediol (pdf) (939.81 KB, February 20, 2020)
• Supporting Information for 3-Methoxybutyl Acetate (pdf) (1008.72 KB, February 20, 2020)
• Supporting Information for 1-Docosanol (pdf) (5.09 MB, February 20, 2020)
• Supporting Information for 1-Eicosanol (pdf) (5.34 MB, February 20, 2020)
• Supporting Information for Squalane (pdf) (1.04 MB, February 20, 2020)